23/08/2024 | Press release | Distributed by Public on 24/08/2024 05:42
Aug 23, 2024 | 1 minute read
Amsterdam, the Netherlands - Royal Philips (NYSE: PHG, AEX: PHIA) today reported that in the period from August 14, 2024 up to and including August 22, 2024 a total of 900,080 of its own common shares were repurchased, with a weighted average purchase price of EUR 26.36. These repurchases were made under the repurchase program to cover certain of the company's obligations arising from its long-term incentive plans, which was announced on August 5, 2024. Since the start of the program, Philips also entered into a forward transaction with a settlement date in November 2026.
Further details can be found via this link.
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 68,700 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
By clicking on the link, you will be leaving the official Royal Philips ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.
I understandYou are about to visit a Philips global content page
ContinueBy clicking on the link, you will be leaving the official Royal Philips ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.
I understandYou are about to visit a Philips global content page
Continue